JBM (Healthcare) Ltd. (HK:2161)
:2161
2161 Stock Chart & Stats
HK$2.77
-HK$0.02(-1.12%)
At close: 4:00 PM EST
HK$2.77
-HK$0.02(-1.12%)
Day’s Range― - ―
52-Week RangeHK$1.47 - HK$3.43
Previous CloseN/A
Volume460.00K
Average Volume (3M)599.79K
Market Cap
HK$2.18B
Enterprise ValueHK$2.35B
Total Cash (Recent Filing)HK$194.20M
Total Debt (Recent Filing)HK$383.18M
Price to Earnings (P/E)5.3
Beta0.08
Next Earnings
Jun 11, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield9.98%
Share Statistics
EPS (TTM)0.14
Shares Outstanding822,000,000
10 Day Avg. Volume515,131
30 Day Avg. Volume599,792
Financial Highlights & Ratios
PEG Ratio0.12
Price to Book (P/B)1.36
Price to Sales (P/S)1.87
P/FCF Ratio7.12
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.33
Revenue Forecast (FY)HK$953.48M
Bulls Say, Bears Say
Bulls Say
High Profitability MarginsSustained high gross and net margins plus strong EBIT/EBITDA indicate durable pricing power and operational efficiency. These margins provide recurring cash generation capacity, support investment and dividends, and make the business more resilient to cost shocks and competitive pressure over months.
Strong Balance Sheet With Low LeverageVery low leverage and a high equity ratio give the company financial flexibility to fund growth, absorb shocks, and pursue strategic investments without stressing liquidity. A healthy ROE near 18% signals effective capital allocation that can persist across business cycles.
Consistent Revenue And EPS GrowthCompound revenue growth alongside outsized EPS growth suggests improving operational leverage and earnings quality over time. Persistent top-line expansion and accelerating EPS underpin the company's ability to reinvest, maintain margins, and support stakeholder returns over the medium term.
Bears Say
Decline In Free Cash Flow GrowthA near-20% drop in free cash flow growth is a structural concern if sustained: it can limit capital spending, acquisitions, and dividend sustainability despite accounting profits. Persistent FCF erosion reduces financial optionality and raises funding risk over several quarters.
Operating Cash Conversion Below Net IncomeOCF converting at 81% of net income implies earnings are not fully translating into cash, possibly from working capital or timing effects. This weakens cash reliability versus reported profits and could constrain durable cash available for reinvestment or payouts if the trend persists.
Revenue Growth Deceleration In Latest YearLatest-year revenue growth of 8.57% is noticeably lower than longer-term growth, signaling potential top-line deceleration. Slower revenue momentum can limit future margin expansion and the company's ability to leverage fixed costs, making earnings growth harder to sustain without market share gains.
JBM (Healthcare) Ltd. News
2161 FAQ
What was JBM (Healthcare) Ltd.’s price range in the past 12 months?
JBM (Healthcare) Ltd. lowest stock price was HK$1.47 and its highest was HK$3.43 in the past 12 months.
What is JBM (Healthcare) Ltd.’s market cap?
JBM (Healthcare) Ltd.’s market cap is HK$2.18B.
When is JBM (Healthcare) Ltd.’s upcoming earnings report date?
JBM (Healthcare) Ltd.’s upcoming earnings report date is Jun 11, 2026 which is in 65 days.
How were JBM (Healthcare) Ltd.’s earnings last quarter?
JBM (Healthcare) Ltd. released its earnings results on Nov 17, 2025. The company reported HK$0.141 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.141.
Is JBM (Healthcare) Ltd. overvalued?
According to Wall Street analysts JBM (Healthcare) Ltd.’s price is currently Overvalued.
Does JBM (Healthcare) Ltd. pay dividends?
JBM (Healthcare) Ltd. pays a Quarterly dividend of HK$0.098 which represents an annual dividend yield of 9.98%. See more information on JBM (Healthcare) Ltd. dividends here
What is JBM (Healthcare) Ltd.’s EPS estimate?
JBM (Healthcare) Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does JBM (Healthcare) Ltd. have?
JBM (Healthcare) Ltd. has 822,000,000 shares outstanding.
What happened to JBM (Healthcare) Ltd.’s price movement after its last earnings report?
JBM (Healthcare) Ltd. reported an EPS of HK$0.141 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.449%.
Which hedge fund is a major shareholder of JBM (Healthcare) Ltd.?
Currently, no hedge funds are holding shares in HK:2161
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
JBM (Healthcare) Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
218.77%
12-Months-Change
Fundamentals
Return on Equity
20.10%
Trailing 12-Months
Asset Growth
25.71%
Trailing 12-Months
Company Description
JBM (Healthcare) Ltd.
JBM (Healthcare) Limited, an investment holding company, develops, manufactures, markets, distributes, and sells healthcare and wellness products in Asia. The company offers consumer healthcare and proprietary Chinese medicines, such as over-the-counter medicines, and medicated and non-medicated solutions, as well as diagnostic devices; and pharmaceutical products. It is also involved in the trading, wholesaling, and retailing of Chinese medicines; trading of medical supplies and pharmaceutical products; and sale of healthcare and herbal products. The company was incorporated in 2020 and is headquartered in Kwun Tong, Hong Kong. JBM (Healthcare) Limited is a subsidiary of JBM Group (BVI) Limited.
Technical Analysis
PuraPharm Corp. Ltd.
―
Dawnrays Pharmaceutical Holdings Ltd.
―
Jacobson Pharma Corporation Limited
―
Zhongzhi Pharmaceutical Holdings Limited
―
Options Prices
Currently, No data available
---